Here’s who qualifies:
The “should” groups—CDC wants these groups to get the shot:
- Anyone 65 years of age or older should get a booster shot.
- Anyone in a long-term care facility should.
- Anyone 50 years old to 64 who has underlying medical conditions should.
The “may” groups—CDC says these groups “may” get the shot. But they should consider whether the benefits outweigh the risks. The reason for this is that these younger groups are usually so well protected already by the first two shots that a booster shot might be wasted on them.
- People 18 to 49 years old with underlying medical conditions can get the third shot.
- People 18 to 64 years old who are at increased risk “because of occupational or institutional setting” can, too.
The decisions about booster shots only concern people who got the Pfizer vaccine. The scientists charged with setting guidelines weren’t ready to discuss whether Moderna and J&J recipients can mix and match with the booster.
CDC director explains why she overruled her advisers
CDC Director Rochelle Wolensky released the following statement on Friday:
“As CDC Director, it is my job to recognize where our actions can have the greatest impact. At CDC, we are tasked with analyzing complex, often imperfect data to make concrete recommendations that optimize health. In a pandemic, even with uncertainty, we must take actions that we anticipate will do the greatest good.
“I believe we can best serve the nation’s public health needs by providing booster doses for the elderly, those in long-term care facilities, people with underlying medical conditions, and for adults at high risk of disease from occupational and institutional exposures to COVID-19. This aligns with the FDA’s booster authorization and makes these groups eligible for a booster shot. Today, ACIP only reviewed data for the Pfizer-BioNTech vaccine. We will address, with the same sense of urgency, recommendations for the Moderna and J&J vaccines as soon as those data are available.
“While today’s action was an initial step related to booster shots, it will not distract from our most important focus of primary vaccination in the United States and around the world. I want to thank ACIP for their thoughtful discussion and scientific deliberation on the current data which informed my recommendation.”
Many scientists are concerned that promoting boosters will divert attention from the most important task: trying to get unvaccinated people in for shots. Others argued that it was important to widely open access to boosters, so the most vulnerable would find them easier to get.
Over the course of meetings with the Food and Drug Administration and the CDC’s Advisory Committee on Immunization Practices this week, heated arguments broke out.
The most contentious disagreement concerned opening up booster shots to adults who encounter a lot of people in their work or institutional settings. While the obvious beneficiaries in that group would be health care workers, opponents argued that that language essentially opened the shots to any adult. The downside would be that all across the country well-protected young people who don’t need a booster would get one anyway, unnecessarily adding more stress to the health system.
So the ACIP members in a split vote decided to oppose giving the shots to the younger group of workers. Hours later, Walensky overruled them.
“As CDC Director, it is my job to recognize where our actions can have the greatest impact,” she said. “In a pandemic, even with uncertainty, we must take actions that we anticipate will do the greatest good.”